Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● Its low valuation, with P/E ratio at 1.97 and 3.22 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.34 for the 2021 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The company has a low valuation given the cash flows generated by its activity.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.